Cognitive Impairment, Sleep Disturbance, and Depression in Women with Silicone Breast Implants: Association with Autoantibodies against Autonomic Nervous System Receptors
Open Access
- 2 June 2022
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 12 (6) , 776
Abstract
Background: Silicone breast implants (SBIs) has been shown to be associated with an increased risk of autoimmune diseases. In the current study, we aimed to explore the potential association between circulating autoantibodies against the autonomic nervous system and cognitive impairment, memory deficit, and depressive symptoms reported by women with SBIs. Methods: ELISA assays were used to quantify anti-adrenergic receptors (α1, α2, β1, β2), anti-muscarinic receptors (M1-M5), anti-endothelin receptor type A, and anti-angiotensin II type 1 receptor titers in the sera of 93 symptomatic female subjects with SBIs and 36 age-matched healthy female controls. Results: A significant difference was detected in the level of autoantibodies against the autonomic nervous system receptors in women with SBIs who reported memory impairment, cognitive impairment, and sleep disturbance as compared with both women with SBIs who did not complain of these symptoms or with healthy individuals without SBIs. Conclusions: Clinical symptoms such as depression, cognitive impairment, and sleep disturbances were found to be associated with dysregulation of the levels of circulating autoantibodies targeting the autonomous nervous system receptors in women with SBIs. These autoantibodies may have diagnostic significance in diseases associated with breast implants.Keywords
Funding Information
- Yaron and Gila Shemie Foundation
This publication has 52 references indexed in Scilit:
- The Slow Afterhyperpolarization: A Target of β1-Adrenergic Signaling in Hippocampus-Dependent Memory RetrievalThe Journal of Neuroscience, 2013
- α2 adrenergic receptor dysregulation in depressive disorders: Implications for the neurobiology of depression and antidepressant therapyNeuroscience & Biobehavioral Reviews, 2012
- Drug‐like actions of autoantibodies against receptors of the autonomous nervous system and their impact on human heart functionBritish Journal of Pharmacology, 2012
- Agonistic Autoantibodies to the α1‐Adrenergic Receptor and the β2‐Adrenergic Receptor in Alzheimer’s and Vascular DementiaScandinavian Journal of Immunology, 2012
- Sera of Patients With Celiac Disease and Neurologic Disorders Evoke a Mitochondrial-Dependent Apoptosis In VitroGastroenterology, 2007
- Anti–N‐methyl‐D‐aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosusArthritis & Rheumatism, 2006
- Behavioral depression in the swim test causes a biphasic, long-lasting change in accumbens acetylcholine release, with partial compensation by acetylcholinesterase and muscarinic-1 receptorsNeuroscience, 2006
- Anti-ribosomal P-protein and its role in psychiatric manifestations of systemic lupus erythematosus: myth or reality?Lupus, 2005
- β1 Adrenergic Receptor-Mediated Enhancement of Hippocampal CA3 Network ActivityThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Receptor-Specific Functional Properties of β2-Adrenergic Receptor Autoantibodies in AsthmaAmerican Journal of Respiratory Cell and Molecular Biology, 1995